---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-058966"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2023-03-03T23:59:59+00:00"
generated_at: "2026-06-18T13:53:33.975992+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Teva prices $2.49B sustainability-linked senior notes; upsizes tender offer to $2.5B

## Summary
- Priced €800M 7.375% notes due 2029, €500M 7.875% notes due 2031, $600M 7.875% notes due 2029, $500M 8.125% notes due 2031.
- Upsized offering from $2.06B to $2.49B equivalent; increased tender offer max from $2.25B to $2.5B.
- Proceeds to fund cash tender offers for six series of existing senior notes due 2023-2026 and repay debt.
- Second sustainability-linked bond issuance; targets include improving medicine access in LMICs and reducing GHG emissions.
- Settlement expected March 9, 2023; notes are unsecured senior obligations guaranteed by Teva.

## SEC filing metadata
- accession: 0001193125-23-058966
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2023-03-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312523058966/0001193125-23-058966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312523058966/d422149d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-058966
- JSON: https://secwatch.observer/filing/0001193125-23-058966.json
- Plain text: https://secwatch.observer/filing/0001193125-23-058966.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.